FDA panel votes 15-1-1 that Abbott's (ABT) Humira benefit is meaningful
Go back to FDA panel votes 15-1-1 that Abbott's (ABT) Humira benefit is meaningful| Abbott Laboratories (NYSE: ABT) | Delayed: 105.27 -0.63 (0.59%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $105.90 | 52 Week High | $46.38 | |||
| Open | $106.50 | 52 Week Low | $36.00 | |||
| Day High | $107.03 | P/E | 70.18 | |||
| Day Low | $104.47 | EPS | $1.50 | |||
| Volume | 7,295,911 | |||||
